Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Dose Response Trial of Pergolide for Cocaine Dependence - 1

This study has been completed.
National Institute on Drug Abuse (NIDA)
Information provided by:
Medical University of South Carolina Identifier:
First received: September 20, 1999
Last updated: September 11, 2012
Last verified: May 1997
The purpose of this study is to evaluate the efficacy and safety of pergolide for treatment of cocaine dependence.

Condition Intervention Phase
Cocaine-Related Disorders
Drug: Pergolide
Phase 3

Study Type: Interventional
Study Design: Primary Purpose: Treatment
Official Title: Dose Response Trial of Pergolide for Cocaine Dependence

Resource links provided by NLM:

Further study details as provided by Medical University of South Carolina:

Primary Outcome Measures:
  • Side effects
  • Drug use
  • Retention
  • Cocaine withdrawal
  • Compliance
  • Effectiveness of medication for global improvements

Estimated Enrollment: 0
Study Start Date: February 1996

Ages Eligible for Study:   21 Years to 50 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Please contact site for information.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00000248

United States, South Carolina
Medical University of South Carolina
Charleston, South Carolina, United States, 29425 742
Sponsors and Collaborators
Medical University of South Carolina
National Institute on Drug Abuse (NIDA)
Principal Investigator: Robert Malcolm, M.D. Medical University of South Carolina
  More Information

Publications: Identifier: NCT00000248     History of Changes
Other Study ID Numbers: NIDA-08355-1
R01DA008355 ( US NIH Grant/Contract Award Number )
Study First Received: September 20, 1999
Last Updated: September 11, 2012

Additional relevant MeSH terms:
Cocaine-Related Disorders
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders
Anesthetics, Local
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents
Vasoconstrictor Agents
Dopamine Uptake Inhibitors
Neurotransmitter Uptake Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Dopamine Agents
Neurotransmitter Agents
Dopamine Agonists processed this record on May 25, 2017